Skip to main content

Providers
Life Sciences
Resources
Project ECHO® Learning Series

Evolving Role of Bispecific Antibodies as Cancer Therapy

Join ACCC, Physicians' Education Resource (PER), and Pharmacy Times Continuing Education (PTCE) for a five-part complimentary tele-mentoring series on the optimal use of bispecific antibodies as cancer immunotherapies.

VIEW RECORDED SESSIONS
OncoLens Resources
All Resources

Blog

Case Studies

Education

CME

News and Events
About
OncoLens provides a first of its kind
multidisciplinary care platform.
More than 10% of all cancer centers and 50% of top pharma in the United States count on OncoLens to help improve outcomes through coordinated patient data, in-depth analysis, and actionable clinical decision support.

5,000,000+

Oncology patients under care within the network

85-90%

Accuracy in AI-driven Patient ID from unstructured data

278,000+

Multidisciplinary case discussions
About OncoLens
About Us

Meet Our Leadership Team

Awards

Meet Our Board of Directors
Contact Us

Careers

Schedule a Demo
Contact Us
Schedule Demo

Education

Stratification of Early-Stage, Non-squamous NSCLC Patients Likely to Benefit from Early, Post-operative Chemotherapy

Topics — EGFR, Exon 19 Deletion, lung cancer, NSCLC

Feb 1, 2021 | Education

MTC: Patient with Stomach Cancer and KIT exon 11 and ATM Mutations

Topics — ATM, gastric cancer, KIT Exon 11

Dec 1, 2020 | Education

Patient with Prostate Cancer and CDK12 and TP53 Mutations

Topics — CDK12, prostate cancer, TP53

Dec 1, 2020 | Education

MTB Discussion for Patients with KIT and CDK12 Mutations

Topics — ATM, CDK12, gastric cancer, KIT Exon 11, prostate cancer, TP53

Dec 1, 2020 | Education

Overview of New CoC Standards

Topics — CoC

Jan 1, 2020 | Education